Friday 6 November 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.

Revenue: +4.15%
EPS: +49.0%
Free cash flow: +49.8%
Total debt: +80.0%

Quarter to September 2026, against a year earlier

212.56 4.56 +2.19%

Follow ILMN

Alert me

Market cap: $31.5B
P/E: 35.6×
Fwd P/E: 46.4×
Dividend yield: —
F-score: 8/9
Altman Z: 4.39
Beneish M: −2.51
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Illumina, Inc. 8-K filed Jun 23, 2026

Period ended Jun 16, 2026 · Filed Jun 23, 2026 · accepted 9:08 AM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers

Red flags

Officer departure Jun 23, 2026
Illumina, Inc. reported the departure of an officer or director

8-K filed Jun 23, 2026 · The filing · sec.gov